Browse by Author "López López, Rafael"

ETV5 and LPP, Promoting EMT in endometrial carcinoma

2011- Barbazán García, Jorge; Alonso Alconada, Lorena; Muinelo Romay , Laura; Abal Posada, Miguel; López López, Rafael [et al.]

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

2012- Barbazán García, Jorge; Alonso Alconada, Lorena; Muinelo Romay , Laura; Abal Posada, Miguel; López López, Rafael [et al.]

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

2014- Alonso Alconada, Lorena; Eritja, N.; Muinelo Romay , Laura; Barbazán García, Jorge; López López, Rafael; [et al.]

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

2014- Anido Herranz, Urbano; Vieito Villar, María; Abalo Piñeiro, Alicia; Muinelo Romay , Laura; Alonso Nocelo, Marta; [et al.]

Exosome-mimetic nanoplatforms for targeted cancer drug delivery

2019- Vázquez Ríos, Abi Judith; Molina-Crespo, A.; López Bouzo, Belén; López López, Rafael; Moreno-Bueno, G.; [et al.]

Explore the role that dmet genotyping platform may play in search of genetic polymorphism associated with severe toxicity

2011- Carracedo Álvarez, Ángel; Candamio Folgar, Sonia; López López, Rafael; Barros Angueira, Francisco; Bernárdez Ferrán, Beatriz; [et al.]

Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients

2019- Ribeiro-Samy, S.; Oliveira, M. I.; Pereira Veiga, Thais; Muinelo Romay , Laura; Carvalho, S.; [et al.]

First analysis of toxicity and treament compliance in customized postoperative chemotherapy based on brca1 levels after NSCLC resection: SCAT (Spanish customized adjuvant therapy) trial. spanish lung cancer group/gecp

2013- López López, Rafael

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

2020- Aranda, Enrique; Viéitez, Jose Maria; Gómez-España, Auxiliadora; Gil Calle, Silvia; Salud-Salvia, Antonieta; [et al.]

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients

2020- León Mateos, Luis Ángel; Abal Posada, Miguel; Casas, H.; Anido Herranz, Urbano; Rapado-Gonzalez, O.; [et al.]

High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion.

2011- Anido Herranz, Urbano; Barbazán García, Jorge; Alonso Alconada, Lorena; Muinelo Romay , Laura; Alonso Nocelo, Marta; [et al.]

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

2019- Villalba, M.; Redin, E.; Exposito, F.; Pajares, M. J.; Sainz, C.; [et al.]

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population

2020- Martinez Lago, Nieves Purificacion; Vieito Villar, María; Varela Ponte, Rafael; Abdulkader Nallib, Ihab; Carrera Álvarez, Juan José; [et al.]

Improving specificity and refining diagnostic accuracy of MRI in breast cancer with dedicated breast PET (dbPET)

2015- López López, Rafael; Cueva Bañuelos, Juan Fernando; Herranz Carnero, Michel; Ruibal Morell, Alvaro; Antúnez López, José Ramón; [et al.]

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

2015- López López, Rafael

Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen

2012- Reboredo Lopez, Margarita; López López, Rafael

Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells

2020- Abreu, M.; Cabezas-Sainz, P.; Pereira Veiga, Thais; Falo, C.; Abalo, A.; [et al.]

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study

2013- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients

2013- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis

2015- De La Fuente González, Alexandre; Alonso Alconada, Lorena; Costa Nogueira, Clotilde; Cuevas Álvarez, Juan; García-Caballero Parada, Tomas; [et al.]

RUNA digital repository

Browse by Author "López López, Rafael"

ETV5 and LPP, Promoting EMT in endometrial carcinoma ﻿

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas ﻿

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas ﻿

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment ﻿

Exosome-mimetic nanoplatforms for targeted cancer drug delivery ﻿

Explore the role that dmet genotyping platform may play in search of genetic polymorphism associated with severe toxicity ﻿

Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients ﻿

First analysis of toxicity and treament compliance in customized postoperative chemotherapy based on brca1 levels after NSCLC resection: SCAT (Spanish customized adjuvant therapy) trial. spanish lung cancer group/gecp ﻿

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial ﻿

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients ﻿

High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion. ﻿

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1 ﻿

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population ﻿

Improving specificity and refining diagnostic accuracy of MRI in breast cancer with dedicated breast PET (dbPET) ﻿

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study ﻿

Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen ﻿

Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells ﻿

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study ﻿

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients ﻿

M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis ﻿

ETV5 and LPP, Promoting EMT in endometrial carcinoma

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

Exosome-mimetic nanoplatforms for targeted cancer drug delivery

Explore the role that dmet genotyping platform may play in search of genetic polymorphism associated with severe toxicity

Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients

First analysis of toxicity and treament compliance in customized postoperative chemotherapy based on brca1 levels after NSCLC resection: SCAT (Spanish customized adjuvant therapy) trial. spanish lung cancer group/gecp

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients

High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population

Improving specificity and refining diagnostic accuracy of MRI in breast cancer with dedicated breast PET (dbPET)

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen

Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients

M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis